These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 15166671)
1. Carcinoma arising from preexisting pregnancy-like and cystic hypersecretory hyperplasia lesions of the breast: a clinicopathologic study of 9 patients. Shin SJ; Rosen PP Am J Surg Pathol; 2004 Jun; 28(6):789-93. PubMed ID: 15166671 [TBL] [Abstract][Full Text] [Related]
2. Pregnancy-like (pseudolactational) hyperplasia: a primary diagnosis in mammographically detected lesions of the breast and its relationship to cystic hypersecretory hyperplasia. Shin SJ; Rosen PP Am J Surg Pathol; 2000 Dec; 24(12):1670-4. PubMed ID: 11117789 [TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic features of cystic hypersecretory lesion of the breast]. Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245 [TBL] [Abstract][Full Text] [Related]
4. Cystic hypersecretory hyperplasia and cystic hypersecretory duct carcinoma of the breast. Pathology, therapy, and follow-up of 39 patients. Guerry P; Erlandson RA; Rosen PP Cancer; 1988 Apr; 61(8):1611-20. PubMed ID: 2832048 [TBL] [Abstract][Full Text] [Related]
5. Coexistence of pregnancy-like and cystic hypersecretory hyperplasia with invasive lobular carcinoma. Takeuchi T; Tsuzuki H; Numoto S; Furihata M Onkologie; 2011; 34(8-9):448-50. PubMed ID: 21934345 [TBL] [Abstract][Full Text] [Related]
6. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma. Goldstein NS; O'Malley BA Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic analysis of breast lesions associated with multiple papillomas. Ali-Fehmi R; Carolin K; Wallis T; Visscher DW Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557 [TBL] [Abstract][Full Text] [Related]
8. Invasive cystic hypersecretory carcinoma of the breast: a rare variant of breast cancer: a case report and review of the literature. Sun J; Wang X; Wang C BMC Cancer; 2019 Jan; 19(1):31. PubMed ID: 30621638 [TBL] [Abstract][Full Text] [Related]
9. Invasive cystic hypersecretory carcinoma of the breast: a case report. Lee JS; Lee YJ J Korean Med Sci; 2004 Feb; 19(1):149-51. PubMed ID: 14966360 [TBL] [Abstract][Full Text] [Related]
10. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Fraser JL; Raza S; Chorny K; Connolly JL; Schnitt SJ Am J Surg Pathol; 1998 Dec; 22(12):1521-7. PubMed ID: 9850178 [TBL] [Abstract][Full Text] [Related]
11. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964 [TBL] [Abstract][Full Text] [Related]
12. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies. Renshaw AA; Cartagena N; Schenkman RH; Derhagopian RP; Gould EW Am J Clin Pathol; 2001 Jul; 116(1):92-6. PubMed ID: 11447758 [TBL] [Abstract][Full Text] [Related]
13. Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy. Moore MM; Hargett CW; Hanks JB; Fajardo LL; Harvey JA; Frierson HF; Slingluff CL Ann Surg; 1997 Jun; 225(6):726-31; discussion 731-3. PubMed ID: 9230813 [TBL] [Abstract][Full Text] [Related]
14. Cystic hypersecretory (in situ) carcinoma of the breast: a clinicopathologic and immunohistochemical characterization of 10 cases with clinical follow-up. D'Alfonso TM; Ginter PS; Liu YF; Shin SJ Am J Surg Pathol; 2014 Jan; 38(1):45-53. PubMed ID: 24121179 [TBL] [Abstract][Full Text] [Related]
15. The role of sentinel node biopsy in ductal carcinoma in situ of the breast. Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312 [TBL] [Abstract][Full Text] [Related]
16. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions? Masood S; Loya A; Khalbuss W Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640 [TBL] [Abstract][Full Text] [Related]
17. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. Liberman L; Cohen MA; Dershaw DD; Abramson AF; Hann LE; Rosen PP AJR Am J Roentgenol; 1995 May; 164(5):1111-3. PubMed ID: 7717215 [TBL] [Abstract][Full Text] [Related]
18. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465 [TBL] [Abstract][Full Text] [Related]
19. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Renshaw AA; Gould EW Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205 [TBL] [Abstract][Full Text] [Related]
20. When is a diagnosis of sclerosing adenosis acceptable at core biopsy? Gill HK; Ioffe OB; Berg WA Radiology; 2003 Jul; 228(1):50-7. PubMed ID: 12738875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]